Sponsored
Learn how to navigate growing complexity, reduce workflow fragmentation, and design access and affordability programs that support patients throughout their treatment journey.
Nicole Eckl, CoverMyMeds
Advertisement
Nicole Eckl is vice president, biopharma sales, at CoverMyMeds.
Articles by Nicole Eckl, CoverMyMeds
As specialty drug launches grow, pharma leaders are rethinking patient access as a core commercialization strategy to reduce delays and improve therapy starts.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
The New Era of Pharma Distribution: Balancing Precision and Scale
2
What Germany's Drug Rebate Hike Means for US Pharma
3
Q&A: What Will It Take to Reshore US Drug Manufacturing?
4
Q&A: How Pharma 3PL Is Evolving Beyond the Pallet
5